News

News Release Jul 17, 2025
Elix Provides AI Drug Discovery Platform “Elix Discovery™” to Eisai
News Release Jul 15, 2025
Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies
Information May 15, 2025
Our Application Scientist, Takahiro Inoue, to Participate as a Speaker in the 29th Tutorial Hosted by the Conference on Biomolecular Screenology (Online)
Information May 14, 2025
Our CEO, Shinya Yuki, to Deliver a Presentation at FJS 2025
Information Apr 17, 2025
Article on Partnership with PRISM BioLab Featured in Nikkei Biotech ONLINE
Information Apr 16, 2025
Article on Partnership with PRISM BioLab Featured in Nikkei
News Release Apr 15, 2025
Elix and PRISM BioLab Join Forces to Accelerate AI-Driven Drug Discovery for Challenging Protein-Protein Interaction Targets
Information Mar 17, 2025
Joint Research Result on Federated Learning with NIMS, Elix, and Partners Published as a Research Paper
Information Feb 27, 2025
Our Members’ Research on Federated Learning Published in Journal of Cheminformatics
Information Jan 27, 2025
Our CEO, Shinya, Gave a Lecture for Graduate Students Studying Abroad at the Institute of Science Tokyo

Contact Us

Thank you for your interest in Elix. If you have any inquiries about our AI drug discovery platform or conducting joint research, or if you would like to conduct an interview with us, please click the Contact button on the right to get in touch with us.
We will respond as soon as possible.